Similarly at 8 weeks , both responder ( lafutidine 52.63 % vs. pantoprazole 56.67 % ; P = 0.712 ) and symptom resolution proportions ( lafutidine 33.33 % vs. pantoprazole 30 % ; P = 0.843 ) were comparable .